Miscellaneous News

RSS

How has the COVID-19 pandemic affected sleep patterns for many US citizens?

A team of scientists recently conducted an online survey to examine the changes in sleep duration among adult US citizens during the COVID-19 pandemic.

9 Apr 2021

Autoantibodies may contribute to severe COVID-19 and potential long-COVID-19 symptoms

New research in the USA and China. investigated how autoantibodies could mediate NETs during a COVID-19 infection. Extensive damage to the body from neutrophil extracellular traps (NETs) after infection may be contributing to thromboinflammation and the symptoms experienced by COVID-19 ‘long-haulers’.

8 Apr 2021

Enhanced neutralization of SARS-CoV-2 South African variant with heterologous adjuvant vaccine candidate

A new study describes the use of a single dose of vaccine based on the viral protein called the receptor-binding domain (RBD) to elicit powerful neutralizing activity against both the Wuhan strain and the most concerning VOC called the South African (SA) strain.

7 Apr 2021

Researchers Identify potent small molecule inhibitors against SARS-CoV-2

A team of scientists from the USA and Sweden has recently screened 8 million small molecule inhibitors against SARS-CoV-2.

5 Apr 2021

Research surveys hygiene practices in food supply chains during COVID-19 pandemic

Researchers survey hygiene procedures in food supply chains implemented during the COVID-19 pandemic.

5 Apr 2021

Muscle strength and mass may predict hospital stay duration in COVID-19 patients

Researchers found that COVID-19 patients with good muscle strength and higher muscle mass had a shorter stay in the hospital.

2 Apr 2021

Long-COVID-19 is a significant risk in recovered patients post-hospitalization

A new study, which appeared in the British Medical Journal, reports on a retrospective study to examine the incidence and risk factors for ‘long COVID-19’, the term used to describe the long-term effects of COVID-19 on affected individuals.

2 Apr 2021

Proper choice of control group nullifies most observed genetic markers for severe COVID-19, study suggests

A new study deals with the genetic contribution to severe disease following infection with this virus, showing that the association of severity with specific human genes described in an earlier study is not obvious.

2 Apr 2021

Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

A new study describes the identification of new compounds from a library, with inhibitory activity against several coronaviruses. This study shows the utility of this method, besides identifying compounds that not only inhibit viral shedding in SARS-CoV-2 cultures, but have an immunomodulatory effect that may be useful in mitigating the damaging cytokine storm typical of severe or critical COVID-19.

2 Apr 2021

Comparative study of SARS, MERS, BAT‐SARS, and SARS-CoV-2

Even though a comparative study on the genomic sequences of SARS-CoV, MERS-CoV, and SARS-CoV-2 is available, there is a gap in the research in regards to the comparison between four types of coronaviruses, namely, SARS-CoV, MERS-CoV, BAT-CoV, and SARS-CoV-2. A new study, which deals with the genomic comparison between the sequence of the above-stated four types of coronaviruses, has been published in the Journal of Medical Virology.

2 Apr 2021

Study discovers new target on SARS-CoV-2 spike for protective antibodies

Researchers at The Scripps Research Institute, USA, have described a potential target for COVID-19 vaccines. Dubbed as CC40.8 bnAb, it exhibited broad reactivity with human beta coronaviruses.

1 Apr 2021

Can asymptomatic COVID-19 confer long-term immunity?

Researchers examined the antibody responses in symptomatic and asymptomatic individuals recovered from COVID-19 to see if there was a discernable difference in their humoral immune responses and long-term protection from reinfection with SARS-CoV-2.

1 Apr 2021

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

A team of researchers recently discussed the potential role of a new assay in bridging a major gap in SARS-CoV-2 research. This assay can throw light on 1) the selection of complementary monoclonal antibody candidates and 2) rapid identification of the immune escape to emerging RBD variants following vaccination or natural infection.

31 Mar 2021

Male fetuses impair the maternal and placental immune response to SARS-CoV-2 infection in pregnancy, finds study

The ongoing COVID-19 pandemic, caused by SARS-CoV-2, is now established to be more likely to lead to symptomatic and serious illness in males relative to females. This may extend as far back as pregnancy, suggests a recent study.

31 Mar 2021

How has the COVID-19 pandemic impacted birth statistics in the U.S.?

A new study examines national-level changes in fertility, preterm birth and other obstetric outcomes, in the U.S., over the period of the pandemic throughout 2020.

29 Mar 2021

Study observes correlation between COVID-19 mortality and autoantibodies in corticosteroid treated patients

Corticosteroid anti-inflammatory drugs have been applied to COVID-19 patients over the course of the pandemic, though the results are mixed. In a recent study, the outcomes for such patients are collated, demonstrating a striking correlation between the development of autoantibodies and mortality.

25 Mar 2021

Correlation of antibody titers with COVID-19 vaccine efficacy

In a new study the relationship between virus-neutralizing antibody and spike protein-binding IgG antibody levels is explored following vaccination by one of seven currently deployed vaccines. The findings support the use of antibody titers as correlates of protection for COVID-19 vaccines.

23 Mar 2021

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

A Korea-based company EyeGene Inc. has recently developed a liposome-based mRNA candidate vaccine against COVID-19, which contains full-length spike protein of the European variant (D614G) of SARS-CoV-2 as a vaccine antigen.

23 Mar 2021

Prediction of antibody responses in recovered COVID-19 patients remains unclear

It is crucial to gain a better understanding of how an antibody response is developed against SARS-CoV-2, and how long it lasts. This will determine the antibody titers and duration that protect against reinfection by the virus. A new preprint on the medRxiv* server shows this to be still a distant goal.

22 Mar 2021

How effective has rapid COVID-19 vaccination been in Israel?

Despite high vaccination rates, analysis shows a definite positive impact, but patience is needed to see the real-world impacts in Israel, a pattern that may hold true in other countries also.

19 Mar 2021

Miscellaneous News

How has the COVID-19 pandemic affected sleep patterns for many US citizens?

Autoantibodies may contribute to severe COVID-19 and potential long-COVID-19 symptoms

Enhanced neutralization of SARS-CoV-2 South African variant with heterologous adjuvant vaccine candidate

Researchers Identify potent small molecule inhibitors against SARS-CoV-2

Research surveys hygiene practices in food supply chains during COVID-19 pandemic

Muscle strength and mass may predict hospital stay duration in COVID-19 patients

Long-COVID-19 is a significant risk in recovered patients post-hospitalization

Proper choice of control group nullifies most observed genetic markers for severe COVID-19, study suggests

Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

Comparative study of SARS, MERS, BAT‐SARS, and SARS-CoV-2

Study discovers new target on SARS-CoV-2 spike for protective antibodies

Can asymptomatic COVID-19 confer long-term immunity?

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Male fetuses impair the maternal and placental immune response to SARS-CoV-2 infection in pregnancy, finds study

How has the COVID-19 pandemic impacted birth statistics in the U.S.?

Study observes correlation between COVID-19 mortality and autoantibodies in corticosteroid treated patients

Correlation of antibody titers with COVID-19 vaccine efficacy

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

Prediction of antibody responses in recovered COVID-19 patients remains unclear

How effective has rapid COVID-19 vaccination been in Israel?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News